INFINITE
Clinical Research Project Management at Harmony

The Latin American population faces a significant susceptibility to emerging diseases, as well as chronic-degenerative illnesses, due to the increased life expectancy, and a dearth of specialized medications. In response, pharmaceutical laboratories have increased research and development programs for new medications in the region, supported by Clinical Research Organizations (CROs). These highly qualified companies streamline and strengthen the processes of conducting and developing clinical research in humans. CROs navigate the complexities of processes and procedures while conducting clinical trials, with the mission of efficiently conducting clinical research processes to confirm the safety and effectiveness profiles of medications under evaluation. This effort aims to support the health and social well-being needs of the region.

To meet the aforementioned standards, CROs boast highly skilled personnel proficient in all facets of clinical research, from initial phases to the final stages, encompassing start-up processes, foreign trade, regional regulatory requirements, and logistical support for patient recruitment. CROs ensure an ethical and privacy framework that safeguards the confidentiality of the participants’ information while also guaranteeing that all the information emanating from the research meets stringent quality standards. These standards are facilitated by advanced mathematical models, to demonstrate that the product will gather the necessary evidence to become a marketable medicine.

At the vanguard of these pharmaceutical challenges is INFINITE, a distinguished CRO, which has been collaborating with pharmaceutical laboratories in this challenge of bringing social well-being within our communities.

INFINITE is a CRO with 22 years of service, a pioneer in the development and management of clinical research projects in the region, attracting research and development projects, and promoting the social well-being of the community. Collaborate in research and development efforts in innovative treatments that allow us to face the new health challenges that society faces such as chronic diseases (diabetes, hypertension, and asthma), health programs, orphan diseases, oncology, and vaccine development, among others.

INFINITE is one of the first and oldest CROs in Mexico committed to improving the quality of human life through innovation and research in the health sector. The company’s flexible and efficient services and solutions are not only limited to collaborating in integral processes for the pharmaceutical industry, but also extend to supporting the medical device, cosmetics, and food industries.

“Our main mission is to defend accountability before the community, recognizing it as our primary objective. Ensuring the safety and effectiveness of the products we test in various trials is our main responsibility,” says Arturo Rodríguez Jacob, CEO of INFINITE.

INFINITE’s commitment to efficiency and community can be demonstrated through its largest project focused on COVID-19. The company recruited eight thousand subjects in a tight four-month period. Due to the unprecedented changes derived from the health emergency, technology emerged as a crucial enabler, facilitating the implementation of research protocols that effectively bridged scientific gaps in response to the pandemic’s evolving landscape.

The company’s deep industrial expertise positions it as a catalyst for global collaboration in advancing clinical research activities. Its internal training program ensures high quality and operational efficiency. Understanding the complexity of the field, INFINITE stands as an adaptive force that provides step-by- step guidance and adapts its approach to meet the diverse needs of clients, whether they are local or international pharmaceutical entities. INFINITE is continually striving to become an invaluable partner for clients seeking not only a service provider but also a collaborative ally committed to their success in the dynamic field of clinical research.

INFINITE believes that its contribution to the development of new drugs helps reduce health disparities and promote social justice within communities.